4.6 Review

Role of lncRNA and EZH2 Interaction/Regulatory Network in Lung Cancer

Journal

JOURNAL OF CANCER
Volume 9, Issue 22, Pages 4156-4165

Publisher

IVYSPRING INT PUBL
DOI: 10.7150/jca.27098

Keywords

lung cancer; lncRNA; EZH2; regulation; interaction

Categories

Funding

  1. National Natural Scientific Foundation of China [81802947, 81472595]
  2. Health and Family Planning Commission of Hunan Province [B20180545]
  3. Natural Science Foundation of Hunan Province [2017JJ2173, 2018JJ3314]
  4. Changsha Science and Technology Board [kq1706045]

Ask authors/readers for more resources

Lung cancer is the leading cause of cancer-related deaths worldwide. Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts and longer than 200 nucleotides. LncRNAs have been demonstrated to modulate gene expression at transcriptional, post-transcriptional, as well as epigenetic levels in lung cancer. Interestingly, compelling studies have revealed that lncRNAs participated in the EZH2 oncogenic regulatory network. EZH2 plays an important role in the initiation, progression and metastasis of cancer. On one hand, lncRNAs can directly bind to EZH2, recruit EZH2 to the promoter region of genes and repress their expression. On the other hand, lncRNAs can also serve as EZH2 effectors or regulators. In this review, we summarized the types of lncRNA-EZH2 interaction and regulatory network identified till date and discussed their influence on lung cancer. Better understanding regarding the interaction and regulatory network will provide new insights on lncRNA- or EZH2-based therapeutic development in lung cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available